Eve & Co confirms second German supply deal for sale of dried cannabis
Category: #business  By Mateen Dalal  Date: 2019-05-31
  • share
  • Twitter
  • Facebook
  • LinkedIn

Eve & Co confirms second German supply deal for sale of dried cannabis

It expects to begin shipments following the estimated Q2 2019 completion of its 780,000 square foot greenhouse extension

Eve & Co has recently announced that Natural MedCo Ltd, its wholly owned subsidiary has entered into a second binding non-exclusive supply deal for the sale of dried cannabis to a distributor and importer in Germany.

Sources close to the matter mentioned that the supply agreement is for an early term of three years and is automatically renewable for two succeeding two-year terms unless it is cancelled by the parties at the end of the renewal or initial term. For the first two months, the German supplier has agreed to buy 500 kg of dried cannabis per month, after which it will purchase a maximum of 5,000 kilograms and a minimum of 1,000 kilograms a month for the next 22 months.

Apparently, the company expects to begin shipments following the estimated Q2 2019 completion of its 780,000 square foot greenhouse extension, and the expected approval thereof from Health Canada.

According to President and CEO of Eve & Co., Melinda Rombouts, this is a very substantial supply deal for Eve & Co as it offers additional access into the German market. The timing fits well with the company’s expected extension facilities coming online and the related acceleration of production, Rombouts said.

Seemingly, under the supply agreement, the sale and purchase of dried cannabis are subject to several conditions precedent, including applicable Germany and Canadian export and import authorizations, and receipt of all requisite regulatory approvals.

Eve & Co has also reportedly announced that the German distributor and importer with respect to the initial German supply agreement of Eve & Co, as announced on 30 Jan 2019, has now received the essential import license from the German government. The company is currently in the process of seeking the essential export permit from Health Canada and expects that it will start shipping product pursuant to this supply deal by the third quarter of 2019.

Source Credit: https://www.globenewswire.com/news-release/2019/05/29/1856759/0/en/Eve-Co-Announces-Second-German-Supply-Agreement-Provides-Update-on-First-German-Supply-Agreement.html

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

Mercedes-AMG Petronas F1 Team and AMD team-up for F1 2020
Mercedes-AMG Petronas F1 Team and AMD team-up for F1 2020
By Mateen Dalal

Mercedes-AMG Petronas F1 Team, and Advanced Micro Devices (AMD), a renowned semiconductor developer, have reportedly announced a new multi-year partnership agreement that has combined the two firms’ passion of for high performance, beginning fr...

Aduro begins trial of MK-5890 for non-small cell lung cancer treatment
Aduro begins trial of MK-5890 for non-small cell lung cancer treatment
By Mateen Dalal

The biopharmaceutical giant has also received a USD 10 million development milestone payment from Merck & CO. for the initiation of the trial A clinical-stage biopharmaceutical company, Aduro Biotech, Inc. recently announced to have ba...

TherapeuticsMD submits a New Drug Application to the FDA for BIJUVA®
TherapeuticsMD submits a New Drug Application to the FDA for BIJUVA®
By Mateen Dalal

TherapeuticsMD, Inc., an inventive pharmaceutical company that focuses on women healthcare, has recently announced that it has presented a New Drug Application (NDA) pre-approval efficacy supplement to the U.S. FDA (Food and Drug Administration) for ...